Field & Main Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Hold
2,535
0.07% 125
2025
Q4
$228K Hold
2,535
0.07% 125
2025
Q3
$250K Sell
2,535
-25
-1% -$2.48K 0.07% 125
2025
Q2
$233K Hold
2,560
0.08% 124
2025
Q1
$290K Hold
2,560
0.1% 118
2024
Q4
$270K Hold
2,560
0.1% 114
2024
Q3
$276K Hold
2,560
0.1% 117
2024
Q2
$278K Hold
2,560
0.1% 114
2024
Q1
$338K Sell
2,560
-135
-5% -$16.9K 0.13% 104
2023
Q4
$328K Hold
2,695
0.14% 107
2023
Q3
$302K Buy
2,695
+1,720
+176% +$218K 0.14% 111
2023
Q2
$142K Hold
975
0.08% 131
2023
Q1
$126K Hold
975
0.08% 134
2022
Q4
$124K Sell
975
-25
-3% -$2.9K 0.08% 134
2022
Q3
$105K Hold
1,000
0.07% 136
2022
Q2
$105K Buy
+1,000
New +$119K 0.07% 139
2022
Q1
Sell
-52
Closed -$6K 233
2021
Q4
$6K Hold
52
﹤0.01% 216
2021
Q3
$7K Hold
52
﹤0.01% 202
2021
Q2
$8K Buy
+52
New +$8.42K 0.01% 196

Other funds holding ZBH

Field & Main Bank's ZBH Position: Q1 2026 in Review

Field & Main Bank held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 2,535 shares worth $229K. The position accounts for 0.07% of the portfolio, ranked #125.

Field & Main Bank first reported a position in ZBH in Q2 2021 and has held it in 19 quarters since. The position peaked at $338K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Field & Main Bank held 2,535 shares of Zimmer Biomet worth $229K as of Q1 2026.
  • Field & Main Bank left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.07% of Field & Main Bank's portfolio in Q1 2026, its #125 holding.
  • Field & Main Bank first reported a position in Zimmer Biomet in Q2 2021 and has held it in 19 quarters since.
  • Field & Main Bank's Zimmer Biomet position peaked at $338K in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.